🔗 Permalink

Assignee profile:

ENTEROME S.A.

City:

Paris

Country:

France

Published Applications:

Last publication date:

2024-10-17

Patent Grants:

Last grant date:

2025-10-21

Top Inventors for applications by ENTEROME S.A.

These are the the leading inventors for applications assigned to ENTEROME S.A.:

Laurent CHENE 11 Neuville aux Bois, France
Francesco STROZZI 7 Paris, France
Matthieu PICHAUD 5 Cambridge, MA United States
Christophe BONNY 4 Paris, France

Alban MATHIEU 3 Saint Foy Les Lyon, France
Alessandra CERVINO 2 Bois-Le-Roi, France
Celia MENDEZ 2 Charlestown, MA United States
Alban MATHIEU 2 Sainte Foy Les Lyon, France

Antoinetta CULTRONE 1 L'hay Les Roses, France
Jan FAGERBERG 1 Paris, France
Joao Gamelas MAGALHAES 1 Corbeil-Essonnes, France
Matthiew Pichaud 1 Cambridge, MA United States

Guillaume KULAKOWSKI 1 Le Kremlin Bicetre, France

Recent patent applications by ENTEROME S.A.

ENTEROME S.A. based in Paris, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-10-17 ✅ Patent 12,447,201 granted on 2025-10-21

US20240342261A1

Human necessities

Immunogenic Compounds For Cancer Therapy

#2 | 2024-03-07 ✅ Patent 12,364,743 granted on 2025-07-22

US20240075117A1

Human necessities

MICROBIOTA SEQUENCE VARIANTS OF TUMOR-RELATED ANTIGENIC EPITOPES

#3 | 2023-06-29 ✅ Patent 12,263,210 granted on 2025-04-01

US20230201322A1

Human necessities

Immunogenic compounds for cancer therapy

#4 | 2023-04-06

US20230105457A1

Chemistry; metallurgy

Immunogenic Compounds For Treatment Of Adrenal Cancer

#5 | 2023-03-16 ✅ Patent 12,059,460 granted on 2024-08-13

US20230080443A1

Human necessities

Immunogenic compounds for cancer therapy

#6 | 2023-03-02

US20230068615A1

Human necessities

Microbiota-Derived Proteins Inducing Il-10 Release From Human Cells And Uses Thereof

#7 | 2022-10-13 ✅ Patent 11,759,508 granted on 2023-09-19

US20220323561A1

Human necessities

Antigenic peptides for treatment of B-cell malignancy

#8 | 2021-04-22 ✅ Patent 12,016,910 granted on 2024-06-25

US20210113678A1

Human necessities

Antigenic peptides for prevention and treatment of cancer

#9 | 2020-04-16 ✅ Patent 11,478,537 granted on 2022-10-25

US20200113983A1

Human necessities

Immunogenic compounds for cancer therapy

#10 | 2020-01-23 ✅ Patent 11,712,465 granted on 2023-08-01

US20200025774A1

Physics

Microbiota sequence variants of tumor-related antigenic epitopes

#11 | 2019-12-26 ✅ Patent 11,478,538 granted on 2022-10-25

US20190388532A1

Human necessities

Immunogenic compounds for cancer therapy

Also check out ENTEROME S.A.'s (Paris, France) applicant profile with 12 patent applications submitted.

AssigneeID:

154073 ⎘